Published in J Otolaryngol on October 01, 1992
PIK3CA mutations in head and neck squamous cell carcinoma. Clin Cancer Res (2006) 1.90
The molecular pathogenesis of head and neck squamous cell carcinoma. J Clin Invest (2012) 1.86
Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer (1996) 1.66
Cost-effectiveness of adding cetuximab to platinum-based chemotherapy for first-line treatment of recurrent or metastatic head and neck cancer. PLoS One (2012) 0.98
Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase II trial. Jpn J Clin Oncol (2013) 0.94
Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptors. Br J Cancer (1994) 0.91
Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance. Oncologist (2013) 0.89
Prevalence of K-RAS Codons 12 and 13 Mutations in Locally Advanced Head and Neck Squamous Cell Carcinoma and Impact on Clinical Outcomes. Int J Otolaryngol (2013) 0.82
HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells. Head Neck (2014) 0.81
Molecular Aspects of Head and Neck Cancer Therapy. Hematol Oncol Clin North Am (2015) 0.77
Prognostic significance of methyl-p-hydroxy-phenyllactate-esterase activity in laryngeal squamous cell carcinoma. Br J Cancer (1998) 0.76
Isolated chloroma: the effect of early antileukemic therapy. Ann Intern Med (1995) 2.29
Intraoperative cone-beam CT for guidance of head and neck surgery: Assessment of dose and image quality using a C-arm prototype. Med Phys (2006) 1.91
Geometric calibration of a mobile C-arm for intraoperative cone-beam CT. Med Phys (2008) 1.65
Investigation of C-arm cone-beam CT-guided surgery of the frontal recess. Laryngoscope (2005) 1.40
Demons deformable registration for CBCT-guided procedures in the head and neck: convergence and accuracy. Med Phys (2009) 1.37
Tufting enteropathy: a newly recognized clinicopathological entity associated with refractory diarrhea in infants. J Pediatr Gastroenterol Nutr (1994) 1.25
Hematopoietic transforming potential of activated ras in chimeric mice. Oncogene (1995) 1.18
Image quality and localization accuracy in C-arm tomosynthesis-guided head and neck surgery. Med Phys (2007) 1.16
B and T cells are not required for the viable motheaten phenotype. J Exp Med (1996) 1.14
Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a crossover design study of unilateral versus bilateral injection. Laryngoscope (2000) 1.07
The free flap and plate in oromandibular reconstruction: long-term review and indications. Plast Reconstr Surg (1995) 1.06
Explaining socioeconomic status effects in laryngeal cancer. Clin Oncol (R Coll Radiol) (2006) 1.05
Adult epiglottitis: the Toronto Hospital experience. J Otolaryngol (1998) 1.02
Informed consent in head and neck surgery: how much do patients actually remember? J Otolaryngol (1997) 0.98
H-ras oncogene mutation and human papillomavirus infection in oral carcinomas. Arch Otolaryngol Head Neck Surg (1994) 0.98
Alterations of the p53 tumor suppressor gene in diffuse large cell lymphomas with translocations of the c-MYC and BCL-2 proto-oncogenes. Blood (1994) 0.97
Glottic cancer in Ontario, Canada and the SEER areas of the United States. Do different management philosophies produce different outcome profiles? J Clin Epidemiol (2001) 0.96
Outcome of oral tongue squamous cell carcinoma in patients with and without known risk factors. Oral Oncol (2010) 0.93
A simple one-step hemolytic assay for C2 with C2-deficient human serum. J Immunol (1977) 0.91
The free iliac crest and fibula flaps in vascularized oromandibular reconstruction: comparison and long-term evaluation. Head Neck (1999) 0.91
Oromandibular reconstruction with the fibular free flap. Analysis of 50 consecutive flaps. Arch Otolaryngol Head Neck Surg (1997) 0.89
Classification of mandibular defects. Plast Reconstr Surg (1993) 0.88
A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck. Laryngoscope (1999) 0.87
Nasopharyngeal brush biopsies and detection of nasopharyngeal cancer in a high-risk population. J Natl Cancer Inst (1999) 0.87
Pharyngocutaneous fistulae in laryngectomy patients: the Toronto Hospital experience. J Otolaryngol (1998) 0.86
Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma. J Clin Oncol (1993) 0.86
Automatic image-to-world registration based on x-ray projections in cone-beam CT-guided interventions. Med Phys (2009) 0.86
Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia. J Otolaryngol (1996) 0.86
Progenitor cell hyperplasia with rare development of myeloid leukemia in interleukin 11 bone marrow chimeras. J Exp Med (1993) 0.85
Reliability and validity of an observer-rated disfigurement scale for head and neck cancer patients. Head Neck (2000) 0.84
Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia. J Otolaryngol (1995) 0.81
The role of computed tomography in the T classification of laryngeal carcinoma. Cancer (2001) 0.81
Internal jugular vein thrombosis following modified neck dissection: implications for head and neck flap reconstruction. Head Neck (1998) 0.81
Supraomohyoid neck dissection. Is it diagnostic or therapeutic? Head Neck (1999) 0.81
Complications associated with rigid fixation of mandibulotomies. J Otolaryngol (1994) 0.80
Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia. Am J Pathol (1989) 0.80
An objective analysis of the impact of lateral rhinotomy and medial maxillectomy on nasal airway function. Laryngoscope (1998) 0.80
Basal cell adenocarcinoma: a rare malignancy of the salivary glands. J Otolaryngol (2000) 0.80
Use of alternative medicine among patients with head and neck cancer. Arch Otolaryngol Head Neck Surg (1999) 0.79
Purification and characterization of a single chain precursor C3-protein (pro-C3) from normal human plasma. J Immunol (1979) 0.79
Eccrine porocarcinoma in a child that evolved rapidly from an eccrine poroma. Med Pediatr Oncol (2001) 0.79
The physiologic reservoir of Epstein-Barr virus does not map to upper aerodigestive tissues. Laryngoscope (1998) 0.79
The free vascularized flap and the flap plate options: comparative results of reconstruction of lateral mandibular defects. Laryngoscope (2000) 0.78
Castleman's disease associated with pemphigus vulgaris. J Am Acad Dermatol (1991) 0.78
Prevalence of human papillomavirus in sinonasal papillomas: a study using polymerase chain reaction and in situ hybridization. Mod Pathol (1992) 0.78
Epstein Barr virus genome in nasopharyngeal carcinomas from New Zealand. Head Neck (2000) 0.78
Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia. J Otolaryngol (1995) 0.77
Tobacco, alcohol, and oral cancer: the patient's perspective. J Otolaryngol (1996) 0.77
Proteolysis of C2 and factor B: analyses of cleavage products by one- and two- dimensional peptide mapping. Mol Immunol (1981) 0.77
Management and outcome of glottic cancer: a population-based comparison between Ontario, Canada and the SEER areas of the United States. Surveillance, Epidemiology and End Results. J Otolaryngol (2000) 0.77
The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma. Blood (1994) 0.76
A retrospective comparison of the morbidity and cost of different reconstructive strategies in oral and oropharyngeal carcinoma. Laryngoscope (1999) 0.75
Facilitation of percutaneous dilational tracheostomy by use of a perforated endotracheal tube exchanger. Chest (1996) 0.75
Unilateral nasal nitric oxide measurement after nasal surgery. Ann Otol Rhinol Laryngol (2000) 0.75
A patient- and observer-rated analysis of the impact of lateral rhinotomy on facial aesthetics. Arch Facial Plast Surg (2001) 0.75
Hemangiopericytoma of the sinonasal tract. J Otolaryngol (1997) 0.75
A case of alpha-fetoprotein-producing gastric cancer. Ann Acad Med Singapore (2001) 0.75
Laryngeal image analysis following botulinum toxin injections in spasmodic dysphonia. J Otolaryngol (1995) 0.75
Lymphoid cell infiltration into Epstein-Barr virus-positive nasopharyngeal carcinomas. Otolaryngol Head Neck Surg (2001) 0.75
Effects of medialization laryngoplasty on airway resistance: a pilot study. Laryngoscope (1999) 0.75
Radiotherapy patterns of practice: T1N0 glottic cancer in Ontario, Canada. Clin Oncol (R Coll Radiol) (2003) 0.75
Effects of botulinum toxin type A injections on aerodynamic measures of spasmodic dysphonia. Laryngoscope (1996) 0.75
Squamous cell carcinomas of the head and neck cultured in floating collagen gels: 1. The maintenance of stromal and epithelial elements in vitro without fibroblast overgrowth. Otolaryngol Head Neck Surg (1997) 0.75
Evaluation of vocal function in unilateral vocal fold paralysis following thyroplastic surgery. J Otolaryngol (1996) 0.75
Sequence preservation of the third exon of the bcl-2 gene in non-Hodgkin's lymphoma: absence of somatic hypermutation. Leukemia (1995) 0.75